Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1575 of 2228 entries
View as:

Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults

Phase: N/A Priority: Normal
NCT ID: NCT00273988 Org: User:
Start: 04/30/02 End: 10/31/03 Due: 10/31/04

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Phase: N/A Priority: Normal
NCT ID: NCT01858961 Org: User:
Start: 05/31/13 End: 07/31/16 Due: 07/31/17

A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)

Phase: N/A Priority: Normal
NCT ID: NCT04138823 Org: User:
Start: 11/26/19 End: 05/17/23 Due: 05/17/24

A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler

Phase: N/A Priority: Normal
NCT ID: NCT03663569 Org: User:
Start: 08/15/18 End: 10/04/19 Due: 10/04/20

Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02215759 Org: User:
Start: 01/31/09 End: - Due: -

LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research

Phase: N/A Priority: Normal
NCT ID: NCT02231164 Org: User:
Start: 10/14/14 End: 12/24/15 Due: 12/24/16

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT06066528 Org: User:
Start: 11/27/23 End: 04/03/26 Due: 04/03/27

Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02183103 Org: User:
Start: 04/30/99 End: - Due: -

A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

Phase: N/A Priority: Normal
NCT ID: NCT05151653 Org: User:
Start: 01/26/22 End: 09/13/24 Due: 09/13/25

A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

Phase: N/A Priority: Normal
NCT ID: NCT05670587 Org: User:
Start: 01/16/23 End: 03/07/24 Due: 03/07/25

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT05741372 Org: User:
Start: 09/07/23 End: 12/30/24 Due: 12/30/25

Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02198352 Org: User:
Start: 06/30/98 End: - Due: -

BI 443651 Methacholine Challenge

Phase: N/A Priority: Normal
NCT ID: NCT03135899 Org: User:
Start: 05/18/17 End: 02/21/18 Due: 02/21/19

Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02173782 Org: User:
Start: 02/28/98 End: - Due: -

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT05670821 Org: User:
Start: 04/18/23 End: 12/31/25 Due: 12/31/26

Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)

Phase: N/A Priority: Normal
NCT ID: NCT01286558 Org: User:
Start: 01/31/11 End: - Due: -

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03843151 Org: User:
Start: 03/19/19 End: 06/03/19 Due: 06/03/20

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04973163 Org: User:
Start: 09/09/21 End: 12/27/25 Due: 12/27/26

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03135548 Org: User:
Start: 05/30/17 End: 11/14/18 Due: 11/14/19

WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02182570 Org: User:
Start: 06/30/01 End: - Due: -

Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05218499 Org: User:
Start: 03/31/22 End: 11/03/25 Due: 11/03/26

Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02248168 Org: User:
Start: 03/31/02 End: - Due: -

Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females

Phase: N/A Priority: Normal
NCT ID: NCT02187562 Org: User:
Start: 07/31/02 End: - Due: -

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02171637 Org: User:
Start: 11/30/03 End: - Due: -

Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03017885 Org: User:
Start: 02/28/17 End: 09/24/22 Due: 09/24/23